Curaleaf

• Curaleaf Enhances Offer to Acquire Aurora Cannabis

  October 5, 2026

  Buyer

  Curaleaf Holdings, Inc.

  Target

  Aurora Cannabis Inc.

  Industry

  Consumer Products

  Location

  Canada

  Type

  Buyout

  Curaleaf increased its takeover offer for Aurora Cannabis, raising implied consideration to US$5.00 per Aurora share and increasing the maximum cap to US$6.00 per share. The revised deal consideration includes Curaleaf subordinate voting shares plus US$1.00 cash per Aurora share, with Curaleaf citing expected synergies and a global cannabis platform rationale.

• Curaleaf Completes Buyout of Remaining 45% Stake in Four 20 Pharma

  May 1, 2026

  Buyer

  Curaleaf Holdings

  Target

  Four 20 Pharma GmbH

  Industry

  Healthcare Services

  Location

  Germany

  Type

  Buyout

  Curaleaf Holdings completed the acquisition of the remaining 45% stake in Four 20 Pharma GmbH, a Germany-based medical cannabis producer and distributor. The deal makes Four 20 Pharma a fully integrated Curaleaf subsidiary and strengthens Curaleaf’s vertically integrated European supply chain from cultivation sources to licensed distribution in Germany.

• Curaleaf Holdings Acquires Minority Stake in Curaleaf International

  July 2, 2025

  Buyer

  Curaleaf Holdings, Inc.

  Target

  Curaleaf International Holdings Limited

  Seller

  Single strategic institutional investor (unnamed)

  Industry

  Consumer Products

  Location

  England, United Kingdom

  Type

  Buyout

  Curaleaf Holdings, Inc. completed the buyout of a single strategic institutional investor's equity stake in Curaleaf International Holdings Limited, bringing Curaleaf's ownership of its European holding company to 100%. The transaction was settled in Curaleaf subordinate voting shares and is intended to strengthen control and accelerate the company's strategic initiatives and expansion across European markets.

• Curaleaf Holdings Acquires Northern Green Canada

  March 19, 2024

  Buyer

  Curaleaf Holdings, Inc.

  Target

  Northern Green Canada Inc.

  Industry

  Pharmaceuticals

  Location

  Ontario, Canada

  Type

  Buyout

  Curaleaf Holdings, Inc. has signed a deal to acquire Northern Green Canada, an EU-GMP certified Canadian licensed cannabis producer, to secure high-quality indoor EU-GMP flower supply and bolster Curaleaf's European and Australasian expansion. The acquisition is expected to close in Q2 2024 pending regulatory approvals and will strengthen Curaleaf's supply chain for key markets including Germany, Australia/New Zealand and the U.K.

• Curaleaf Acquires Deseret Wellness

  March 29, 2023

  Buyer

  Curaleaf Holdings, Inc.

  Target

  Deseret Wellness

  Industry

  Retail

  Location

  Utah, United States

  Type

  Buyout

  Curaleaf Holdings, Inc. agreed to acquire Deseret Wellness in a cash-and-stock transaction valued at approximately US$20 million. The deal adds three medical cannabis dispensaries in Park City, Provo and Payson (combined annualized revenue ~$14 million), expanding Curaleaf’s Utah retail footprint to four dispensaries and its nationwide store count to about 150.

• Curaleaf Holdings Acquires Tryke Companies (Reef Dispensaries)

  October 5, 2022

  Buyer

  Curaleaf Holdings, Inc.

  Target

  Tryke Companies (dba Reef Dispensaries)

  Industry

  Retail

  Location

  Nevada, United States

  Type

  Buyout

  Curaleaf Holdings, Inc. has completed the acquisition of Tryke Companies (dba Reef Dispensaries), a vertically integrated multi-state cannabis operator, expanding Curaleaf's cultivation and retail footprint across Arizona, Nevada and Utah. The transaction included cash and Curaleaf subordinate voting shares with total consideration of approximately US$181 million plus contingent shares tied to 2022 EBITDA targets, and is expected to be immediately accretive to Curaleaf's EBITDA and free cash flow.

• Curaleaf Acquires Bloom Dispensaries

  December 28, 2021

  Buyer

  Curaleaf Holdings, Inc.

  Target

  Bloom Dispensaries

  Industry

  Consumer Products

  Location

  Arizona, United States

  Type

  Buyout

  Curaleaf Holdings, Inc. agreed to acquire Bloom Dispensaries, a vertically integrated single-state cannabis operator in Arizona, in an all-cash transaction valued at approximately US$211 million. The deal adds four retail dispensaries (Phoenix, Tucson, Peoria, Sedona) plus ~63,500 sq. ft. of adjacent cultivation and processing space in north Phoenix; Curaleaf will pay $51 million cash at close and the remainder via three promissory notes, and Bloom generated estimated 2021 revenue of ~$66 million with EBITDA margins above 40%.

• Curaleaf Acquires Los Sueños Farms

  May 17, 2021

  Buyer

  Curaleaf Holdings, Inc.

  Target

  Los Sueños Farms

  Industry

  Retail

  Location

  Colorado, United States

  Type

  Buyout

  Curaleaf Holdings agreed to acquire Los Sueños Farms, a large outdoor cannabis cultivation operator in Pueblo, Colorado, including 66 acres of outdoor cultivation, an 1,800-plant indoor grow and two retail dispensaries. The approximately $67 million deal (mix of stock, cash and assumed debt, plus contingent stock consideration) expands Curaleaf’s low‑cost cultivation capacity and vertically integrates its Colorado operations to support wholesale and Select-branded product distribution.

• Curaleaf Acquires EMMAC Life Sciences

  March 9, 2021

  Buyer

  Curaleaf Holdings, Inc.

  Target

  EMMAC Life Sciences Limited

  Industry

  Healthcare Services

  Location

  England, United Kingdom

  Type

  Buyout

  Curaleaf Holdings announced a definitive agreement to acquire EMMAC Life Sciences Limited for approximately US$286 million (85% in Curaleaf shares, 15% cash) plus up to US$57 million of contingent earn-outs. The acquisition gives Curaleaf a developed, vertically integrated platform for entry into the European medical cannabis market, including cultivation, EU‑GMP processing, distribution and R&D across key EU markets.

Related Acquisition Pages